Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm
Vijayalakshmi Chelliah, Georgia Lazarou, Sumit Bhatnagar, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 605-618
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview
Vijayakumar Shrihastini, Pandiyan Muthuramalingam, Sivakumar Adarshan, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6222-6222
Open Access | Times Cited: 65
Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities
Nadia Terranova, Karthik Venkatakrishnan, Lisa J. Benincosa
The AAPS Journal (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 57
Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model
Álvaro Ruiz-Martínez, Chang Gong, Hanwen Wang, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 7, pp. e1010254-e1010254
Open Access | Times Cited: 46
Deciphering albumin-directed drug delivery by imaging
Huiyu Hu, Jeremy M. Quintana, Ralph Weissleder, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114237-114237
Open Access | Times Cited: 42
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development
Wei Gao, Jiang Liu, Blerta Shtylla, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 13, Iss. 5, pp. 691-709
Open Access | Times Cited: 23
A comprehensive review of computational cell cycle models in guiding cancer treatment strategies
Chenhui Ma, Evren Gürkan-Çavusoglu
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling
Hanwen Wang, Theinmozhi Arulraj, Alberto Ippolito, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 9
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
Hanwen Wang, Huilin Ma, Richard J. Sové, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e002100-e002100
Open Access | Times Cited: 44
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Richard J. Sové, Babita K. Verma, Hanwen Wang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005414-e005414
Open Access | Times Cited: 35
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
Hanwen Wang, Chen Zhao, Cesar A. Santa‐Maria, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104702-104702
Open Access | Times Cited: 32
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition
Hanwen Wang, Theinmozhi Arulraj, Holly Kimko, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 20
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition
Theinmozhi Arulraj, Hanwen Wang, Leisha A. Emens, et al.
Science Advances (2023) Vol. 9, Iss. 26
Open Access | Times Cited: 18
Towards systems immunology of critical illness at scale: from single cell ‘omics to digital twins
Yoram Vodovotz
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 345-355
Open Access | Times Cited: 17
Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology
Theinmozhi Arulraj, Hanwen Wang, Alberto Ippolito, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 7
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery
Shuming Zhang, Atul Deshpande, Babita K. Verma, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2734-2748
Closed Access | Times Cited: 7
Toward Project Optimus for Oncology Precision Medicine: Multi‐Dimensional Dose Optimization Enabled by Quantitative Clinical Pharmacology
Karthik Venkatakrishnan, Piet H. van der Graaf
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 5, pp. 927-932
Open Access | Times Cited: 25
Emulation of Quantitative Systems Pharmacology models to accelerate virtual population inference in immuno-oncology
Tomasz Pawłowski, Grzegorz Bokota, Georgia Lazarou, et al.
Methods (2024) Vol. 223, pp. 118-126
Closed Access | Times Cited: 5
A Systematic Review of the Efforts and Hindrances of Modeling and Simulation of CAR T-cell Therapy
Ujwani Nukala, Marisabel Rodriguez Messan, Osman N. Yoğurtçu, et al.
The AAPS Journal (2021) Vol. 23, Iss. 3
Closed Access | Times Cited: 26
Pediatric oncology drug development and dosage optimization
S. Y. Amy Cheung, Justin L. Hay, Yu-Wei Lin, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 3
Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalities
Ya-ting Zhou, Jiahui Chu, Shuhan Zhao, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1287-1304
Open Access | Times Cited: 3
Moving the needle for oncology dose optimization: A call for action
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 6, pp. 909-918
Open Access | Times Cited: 3
Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice
Alexander Kulesza, Claire Couty, Paul Lemarre, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2024) Vol. 51, Iss. 6, pp. 581-604
Closed Access | Times Cited: 3
Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
Atiqur Rahman, Mirat Shah, Stacy S. Shord
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 577-591
Open Access | Times Cited: 3
How Should Cancer Models Be Constructed?
Robert A. Beckman, Irina Kareva, Frederick R. Adler
Cancer Control (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 26
Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
Mario Giorgi, Rajat Desikan, Piet H. van der Graaf, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 10, pp. 1130-1133
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top